Skip to main content
. 2022 Sep 24;2(4):198–204. doi: 10.1016/j.jncc.2022.09.001

Fig. 1.

Fig 1

Survival analyses of the overall population and by treatment group. (A) OS of overall population. (B) BCSS of overall population. (C) Comparison of OS between the two treatment groups before PSM. (D) Comparison of BCSS between the two treatment groups before PSM. (E) Comparison of OS between the two treatment groups after PSM. (F) Comparison of BCSS between the two treatment groups after PSM. ALND, axillary lymph node dissection; BCSS, breast cancer-specific survival; OS, overall survival; PSM, propensity score matching.